How efficient is patient discharge following lower limb arthroplasty? by Ashby, Elizabeth et al.
Perioperative
Medicine 
Ashby et al. Perioperative Medicine  (2015) 4:5 
DOI 10.1186/s13741-015-0015-yRESEARCH Open AccessHow efficient is patient discharge following lower
limb arthroplasty?
Elizabeth Ashby1*, Claire Matejowsky2, Michael G Mythen3, Fares S Haddad4 and Michael PW Grocott3,5,6Abstract
Background: Appropriately timed patient discharge is essential for optimal patient care and efficient hospital
functioning. The post-operative morbidity survey (POMS) is the only validated prospective method of measuring
short-term post-operative morbidity. It has not previously been used as a bed utilisation tool.
Methods: We collected POMS data from 529 consecutive lower-limb arthroplasty patients over a 1-year period and
recorded the number of patients remaining in the hospital without morbidity, together with alternative reasons for
remaining in hospital. Data was collected on post-operative days (POD) 3, 5, 8 and 15.
Results: On POD 3, 45% of hip arthroplasty patients and 52% of knee arthroplasty patients remained in hospital
with no identifiable morbidity. On POD 5, 53% of hip arthroplasty patients and 47% of knee arthroplasty patients
remained in hospital with no identifiable morbidity. These figures declined by POD 8 and 15. The most common
reason for inappropriate bed occupancy was ongoing physiotherapy and occupational therapy.
Conclusions: We believe POMS is able to identify patients remaining in hospital with no significant morbidity and
has utility as a prospective bed utilisation tool. Addition of a mobility measure to POMS may improve its utility in
detecting morbidity requiring hospitalisation, particularly following lower limb arthroplasty.
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Appropriately timed discharge of patients following sur-
gery is essential for optimal patient care and efficient hos-
pital functioning. A patient discharged early is at risk of
under-diagnosis of medical complications with consequent
adverse outcome. A patient whose discharge is delayed is
at risk of developing a hospital-associated complication
(for example, hospital-acquired infection) and incurs an
unnecessary cost to the health-care provider. Post-
operative patients should be discharged at the earliest safe
opportunity to reduce the rate of hospital-associated com-
plications and the cost of each in-patient episode. Appro-
priate discharge timing should increase the throughput of
patients and reduce waiting times.
Historically, hospitals in the UK have been paid accord-
ing to contracts with no financial incentive to treat in-
creased numbers of patients. This changed in 2000 when
the National Health Service (NHS) Plan [1] announced* Correspondence: elizabethashby@doctors.org.uk
1Catterall Unit, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore,
Middlesex HA7 4LP, UK
Full list of author information is available at the end of the article
© 2015 Ashby et al.; licensee BioMed Central .
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.that hospital incomes would be directly linked to activity.
Payment by results [2] began in 2003 and now every
healthcare provider is paid a sum (tariff) for each proced-
ure undertaken. In the UK, many patients remain in hos-
pitals with no medical indication [3]. One study showed
that 31% of post-operative patients remained in hospitals
inappropriately [4]. Payment by results aims to reduce this
figure by rewarding efficiency and encouraging increased
activity.
In order to improve efficiency, hospitals must first rec-
ognise inappropriate bed occupancy. The post-operative
morbidity survey (POMS) [5] is the only validated pro-
spective method of measuring short-term post-operative
morbidity in the literature. POMS was designed to iden-
tify morbidity of a type and severity that could delay
hospital discharge. The survey focuses on indicators of
organ system dysfunction (for example, inability to toler-
ate enteral diet) rather than traditional diagnostic cat-
egories (for example, deep vein thrombosis). POMS
assesses nine domains of morbidity (Table 1). Data is ob-
tained from observation charts, medication charts, patientThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Criteria for a positive POMS score
Variable Criteria for positive result
Pulmonary Requires supplementary oxygen or ventilatory
support
Infection Currently on antibiotics or temperature >38°C in
the last 24 hours
Renal Oliguria (<500 ml/day), elevated creatinine
(>30% pre-op level), catheter in situ (for
non-surgical reason)
Gastrointestinal Unable to tolerate enteral diet for any reason
Cardiovascular Diagnostic tests or treatment within the last
24 h for: myocardial infarction, hypotension
(requiring pharmacological therapy or fluids >
200 ml/h), atrial/ventricular arrhythmia or
cardiogenic pulmonary oedema
Central nervous
system
Presence of new focal deficit, coma, confusion or
delirium
Wound
complications
Wound dehiscence requiring surgical exploration or
drainage of pus from operative wound with or
without isolation of organisms
Haematological Requirement of blood transfusion, platelets, fresh
frozen plasma, or cryoprecipitate within the last 24 h
Pain Wound pain requiring parenteral opioids or regional
anaesthesia
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tioning and observation. No additional investigations are
required. The data collection process is simple to allow
routine screening of large numbers of patients. POMS has
been shown to be reliable, valid and acceptable to patients
[6]. POMS has been used in outcomes research [7] and in
effectiveness research [8].
In the US, over 98% of post-operative in-patients had
morbidity defined by POMS [5]. This implies that pa-
tients with a POMS score of 0 are fit for discharge.
Therefore, as well as providing useful clinical research
and audit data, POMS may have utility for assessing and
improving hospital bed utilisation.
The aim of this study is to identify inappropriate bed
occupancy following lower limb arthroplasty using
POMS. We report the reasons for delayed discharge and
suggest ways to improve bed utilisation.
Methods
Ethical approval was gained from the Joint UCLH/UCL
Committee on the Ethics of Human Research (ref. num-
ber 01/0116) prior to commencement of the study. The
requirement for consent was waived as collection of
POMS has become a routine part of service evaluation
within our institution. All patients aged 18 or over
undergoing elective lower limb arthroplasty at University
College Hospitals NHS Trust over a 12-month period
were eligible for inclusion into this prospective cohort
study. There were no exclusion criteria ensuring a consecu-
tive sample was taken. Elective lower limb arthroplastyprocedures included unicompartmental knee replacement
(UKR), total knee replacement (TKR), revision total knee
replacement, hip resurfacing (HR), total hip replacement
(THR) and revision total hip replacement.
Data was collected by one of two study nurses. The age,
sex, American Society of Anesthesiologists (ASA) physical
status score and length of in-patient stay for each patient
were recorded. POMS data were collected on post-
operative days (POD) 3, 5, 8 and 15 if the patient
remained in hospital. Presence of morbidity was defined
as occurring in any patient meeting POMS criteria in one
or more domains of the survey on the day of data collec-
tion. For patients remaining in hospital without morbidity
on POD 8 and POD 15, the reason was recorded. The use
of mobility aids on these days was also noted.
The number and percentage of patients with no identi-
fiable morbidity according to POMS was calculated for
POD 3, 5, 8 and 15. The number of days each patient
remained in hospital with no morbidity was calculated
by distracting the day on which the patient first had a
POMS score of 0 from his or her total length of stay. An
overall estimated cost saving was calculated by multiply-
ing this figure by the average cost for one orthopaedic
in-patient night.
The number of patients developing postoperative mor-
bidity after a period free of morbidity was recorded. The
number of readmissions to the same hospital in the first
year following discharge was also recorded.
Results
Data collection was completed on 529 patients. Patient
characteristics of the study population are shown in
Table 2. The mean age of all study patients was 68.9 years,
the median ASA physical status score was 2 and 62% of
patients were female. The median length of stay was
7 days, and the overall in-patient mortality rate was 0.4%.
A) Hip arthroplasty patients
The location of hip arthroplasty patients on POD 3, 5, 8
and 15 is shown in Table 3. Many patients undergoing
HR remained in the hospital with no identified morbid-
ity on POD 3 (75%), 5 (78%) and 8 (16%). All HR pa-
tients had been discharged by POD 15.
Many THR patients remained in hospital with no identi-
fiable morbidity on POD 3 (46%), 5 (54%), 8(34%) and 15
(7%). Patients undergoing revision THR patients remained
in the hospital with no identifiable morbidity on POD 3
(11%), 5 (29%), 8 (31%) and 15 (3%). Discharge status and
prevalence of morbidity for all hip arthroplasty patients
combined are presented in Figure 1.
B) Knee arthroplasty patients
The location of knee arthroplasty patients on POD 3, 5,
8 and 15 is shown in Table 4. Many patients undergoing
Table 2 Demographics of the study population
Number
performed
Mortality
rate (%)
Age (years) ASA physical status score % Male Length of stay (days)
Mean Range Median Range Median Range
UKR 66 1 66.1 45 to 87 2 1 to 3 45 5 2 to 52
TKR 226 0 70.3 23 to 90 2 1 to 3 36 6 3 to 37
RTKR 8 0 71.6 46 to 88 2 1 to 3 25 13 3 to 102
HR 32 0 51.6 22 to 70 1 1 to 3 50 6 4 to 13
THR 162 0 70.7 21 to 89 2 1 to 3 36 8 3 to 51
RTHR 35 3 72.2 26 to 88 2 1 to 3 36 14 6 to 93
Total 529 0.4 68.9 21 to 90 2 1 to 3 38 7 2 to 102
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bidity on POD 3 (63%), 5 (39%) and 8 (6%). All UKR pa-
tients had been discharged by POD 15.
Many TKR patients remained in the hospital with no
identifiable morbidity on POD 3 (50%), 5 (50%), 8 (19%)
and 15 (4%). Revision TKR patients remained in the hos-
pital with no identifiable morbidity on POD 3 (52%), 5
(47%), 8 (17%) and 15 (3%). Discharge status and preva-
lence of morbidity for all knee arthroplasty patients
combined are presented in Figure 2.
C) Overall inappropriate bed occupancy days
Table 5 shows the average number of days that post-
operative patients remained in the hospital with no iden-
tifiable morbidity. HR patients stayed an average of
2.36 days with no morbidity, THR patients 4.19 days and
revision THR patients 10.37 days. UKR patients stayed
an average of 1.76 days with no identifiable morbidity,
TKR patients 2.73 days and revision TKR patients
14.38 days.
D) Cost of inappropriate bed occupancy days
529 patients were included in this study. These patients
remained in the hospital for a total of 1,965 days withTable 3 Location of patients following hip arthroplasty
POD 3
Procedure HR Patients discharged 0/32 (0%
Inpatients POMS >0 8/32 (25%
Inpatients POMS = 0 24/32 (75
THR Patients discharged 0/162 (0%
Inpatients POMS >0 87/162 (5
Inpatients POMS = 0 75/162 (4
Revision THR Patients discharged 0/35 (0%
Inpatients POMS >0 31/35 (89
Inpatients POMS = 0 4/35 (11%
TOTAL Patients discharged 0/230 (0%
Inpatients POMS >0 127/230
Inpatients POMS = 0 103/230no morbidity as defined by POMS. A surgical in-patient
bed costs up to £400 per night [9]. If these patients had
been discharged when their POMS score was 0, a saving
of up to £786,000 could have been made.E) Reasons for patients with no morbidity remaining in
hospital
Of the 529 patients participating in this study, 120
remained in hospital with no morbidity defined by
POMS on POD 8, and 20 patients remained with no
identifiable morbidity on POD 15. The reasons for non-
discharge are shown in Figure 3. The most common rea-
son is continuing physiotherapy and occupational therapy
input. Other reasons include waiting for home equipment,
waiting for a rehabilitation bed, waiting for a social ser-
vices package of care and patients feeling unwell with
negative investigations.
Of the patients remaining in hospital with no morbid-
ity identified by POMS, 24% were mobilising with a zim-
mer frame, 55% were mobilising with two crutches, 14%
with a single crutch and 7% were mobilising unaided.
This study did not record how far patients could mobil-
ise or whether they could climb stairs.POD 5 POD 8 POD 15
) 2/32 (6%) 27/32 (84%) 32/32 (100%)
) 5/32 (16%) 0/32 (0%) 0/32 (0%)
%) 25/32 (78%) 5/32 (16%) 0/32 (0%)
) 13/162 (8%) 78/162 (48%) 138/162 (85%)
4%) 62/162 (38%) 29/162 (18%) 13/162 (8%)
6%) 87/162 (54%) 55/162 (34%) 11/162 (7%)
) 0/35 (0%) 3/35 (9%) 20/35 (57%)
%) 25/35 (71%) 21/35 (60%) 14/35 (40%)
) 10/35 (29%) 11/35 (31%) 1/35 (3%)
) 16/230 (7%) 109/230 (47%) 191/230 (83%)
(55%) 92/230 (40%) 50/230 (22%) 27/230 (12%)
(45%) 122/230 (53%) 71/230 (31%) 12/230 (5%)
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Figure 1 Discharge status and prevalence of morbidity following all types of hip arthroplasty.
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Thirty-eight out of 529 patients developed morbidity as an
in-patient following a period without morbidity. Five of
these patients underwent a second surgical procedure and
developed morbidity in the second post-operative period.
Thirty patients (6.2%) developed morbidity following a
period without morbidity. Twenty-five of these patients
developed wound morbidity: 24 patients had no morbidity
on POD 3 but developed wound morbidity by POD 5, and
1 revision arthroplasty patient had no morbidity on POD
5 but developed wound morbidity by POD 8. Six patients
developed cardiovascular morbidity after a period with no
morbidity: 5 patients were prescribed anticoagulation (2
for pulmonary embolus and 3 for deep vein thrombosis)
and 1 patient had a myocardial infarction. One patient de-
veloped neurological morbidity (a cerebro-vascular acci-
dent) after a period without morbidity, and 1 patient
developed infectious morbidity (an infected peripheral
cannula site) after a period without morbidity.Table 4 Location of patients following knee arthroplasty
Day 3 post
Procedure UKR Patients discharged 7/66 (11%)
Inpatients POMS >0 17/66 (26%)
Inpatients POMS = 0 42/66 (63%)
TKR Patients discharged 0/226 (0%)
Inpatients POMS >0 114/226 (50
Inpatients POMS = 0 112/226 (50
Revision TKR Patients discharged 0/8 (0%)
Inpatients POMS >0 6/8 (75%)
Inpatients POMS = 0 2/8 (25%)
TOTAL Patients discharged 7/300 (2%)
Inpatients POMS >0 137/300 (46
Inpatients POMS = 0 156/300 (52No patient in this study was readmitted to the same
hospital in the first year following discharge for any rea-
son relating to their surgery.
Discussion
This study identifies many patients remaining in hospital
with no identifiable morbidity following lower-limb
arthroplasty in a UK teaching hospital. The rate of in-
appropriate bed occupancy varies with time after surgery
and type of arthroplasty.
The most common reason for patients remaining in
hospital with no identifiable morbidity was ongoing
physiotherapy and occupational therapy. This suggests
that improving pre- and post-operative planning could
improve appropriate bed occupancy. Patients could be
taught post-operative physiotherapy exercises in group
classes prior to surgery. Occupational therapists could
assess each patient’s home environment and ensure ne-
cessary modifications are made. In the post-operative-op Day 5 post-op Day 8 post-op Day 15 post-op
33/66 (50%) 59/66 (89%) 65/66 (98%)
7/66 (11%) 3/66 (5%) 1/66 (2%)
26/66 (39%) 4/66 (6%) 0/66 (0%)
22/226 (10%) 145/226 (64%) 211/226 (93%)
%) 90/226 (40%) 38/226 (17%) 7/22 (3%)
%) 114/226 (50%) 43/226 (19%) 8/226 (4%)
1/8 (13%) 1/8 (13%) 6/8 (75%)
4/8 (50%) 5/8 (62%) 1/8 (12.5%)
3/8 (37%) 2/8 (25%) 1/8 (12.5%)
56/300 (19%) 205/300 (68%) 282/300 (94%)
%) 101/300 (34%) 46/300 (15%) 9/300 (3%)
%) 143/300 (47%) 49/300 (17%) 9/300 (3%)
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Figure 2 Discharge status and prevalence of morbidity following all types of knee arthroplasty.
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maximum therapy input at the earliest possible oppor-
tunity. Some physiotherapy and occupational therapy
could be provided post-operatively in a rehabilitation
unit or at the patient’s home rather than in hospital.
This would require safety and cost evaluation prior to
implementation.
Three of the top five reasons for patients remaining in
hospital with no identifiable morbidity relate to ‘social’
issues (awaiting home equipment, awaiting a rehabilita-
tion bed, awaiting a package of care from social ser-
vices). Pre-operative clinics could identify and address
these problems prior to admission. Such clinics could
also be used to manage patient expectation so they are
aware of the difficulties they may encounter in the post-
operative period and the expected timing of discharge.
This study has several strengths. A large consecutive
dataset was collected prospectively using a validated
methodology for measuring post-operative morbidity.
This is the first published study to prospectively evaluateTable 5 Number of inappropriate inpatient days classified
by type of arthroplasty
Total number
of patients
Total number
of inappropriate
in-patient days
Average number
of inappropriate
in-patient days
per patient
HR 33 78 2.36
THR 162 678 4.19
Revision THR 35 363 10.37
UKR 63 111 1.76
TKR 227 620 2.73
Revision TKR 8 115 14.38
Total 528 1965 3.72the appropriateness of discharge following lower limb
joint replacement surgery.
The weaknesses of this study are that it was conducted
in a single centre, POMS is not validated as a bed util-
isation tool, there was not daily recording of data so the
calculation of excess days are an approximation, and pa-
tient mobility was not fully assessed. Data was collected
regarding mobility aids, but the distance each patient
could mobilise was not recorded.
This is the first time that POMS has been used as a
bed utilisation tool. It has not been validated for this
purpose but has previously been used to identify patients
in hospitals without morbidity [5,6]. In the US, over 98%
of in-patients had morbidity defined by POMS [5] sug-
gesting that patients with POMS score of 0 were rapidly
discharged. In a previous UK study, 63% of orthopaedic
patients remained in hospital with no morbidity on POD
3 and 42% on POD 5 suggesting that discharge efficiency
was lower in the UK institution. In the US, many post-
operative arthroplasty patients are discharged to a re-
habilitation unit. This practice is far less common in the
UK and may partially account for the discrepancy in dis-
charge efficiency.
Use of POMS as a bed utilisation tool relies on the as-
sumption that it captures all reasons for remaining in
hospital. In this study, the main reason for remaining in
hospital with no identifiable morbidity was ‘ongoing
physiotherapy and occupational therapy input’. A spe-
cific concern in this patient group, who are often elderly
and frail, is that they may not have adequate mobility to
be discharged safely. Including a specific domain for mo-
bility may improve the sensitivity of POMS for morbidity
requiring hospitalisation following orthopaedic surgery.
The domain should assess the ability to walk short dis-
tances, ability to climb a flight of stairs and a balance
and falls assessment. Whilst this domain could be
Patient not eating
1%
Unstable blood glucose 
levels
1% Awaiting appropriate 
warfarin levels
1%
Awaiting social services 
package of care
9%
Patient feeling 
depressed
1%
Awaiting bed in 
rehabilitation hospital
9%
Awaiting equipment at 
home
11%
Unwell but all 
investigations negative
9%
On-going PT 
and /or OT input
58%
Figure 3 Reasons lower-limb arthroplasty patients with no morbidity remained in the hospital on post-operative days 8 and 15.
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further investigation.
Use of POMS as a ‘fitness for discharge’ tool rests on the
assumption that patients do not develop new morbidity
after they have become free from morbidity, either in hos-
pital or following discharge. No patients were readmitted
to the study hospital in the first post-operative year for
complications linked to surgery. However, 33 patients
(6.2%) developed ‘new’ morbidity following a period with-
out morbidity whilst in hospital. This highlights a limita-
tion of prospectively using POMS as a ‘fitness for
discharge’ tool. 25 of 33 (76%) of these patients developed
wound morbidity after a period with no morbidity. To
overcome this potential problem, primary arthroplasty pa-
tients should have regular wound reviews until POD 5 and
revision arthroplasty patients until POD 8. This could be
performed in an outpatient or primary care setting by a
doctor or nurse. Extra capacity would be needed to ensure
no negative impact on existing services. This would add
cost to each patient episode but would be more cost ef-
fective than patients remaining in hospital. Patients should
be aware of the risk of deep vein thrombosis, pulmonary
embolus, myocardial infarction and cerebro-vascular acci-
dent following discharge and receive clear written instruc-
tions regarding symptoms and management. As long as
these precautionary measures are in place, POMS has po-
tential as a bed utilisation tool.
The most commonly used tool to assess appropriate
bed utilisation in the literature is the AppropriatenessEvaluation Protocol (AEP) [10]. AEP is a retrospective
tool that relies on data from the inpatient record. It
has been shown to be valid and reliable in some stud-
ies [10] but not in others [11]. POMS is a prospective
tool that could be used in real time to assist with ap-
propriate patient discharge. AEP is a retrospective tool
that can only be used to evaluate past events. Data for
POMS is collected directly from contemporary data
sources whilst the patient is in hospital; AEP relies solely
on past patient records and is therefore dependent on
completeness and accuracy of record keeping for reliable
functioning.
AEP has been used in several European countries to
examine bed utilisation. In Portugal, 50% of inpatient
days were deemed inappropriate [12], in Italy 37.3% [3],
in Germany 28% [13], in Switzerland 8% to 15% [14] and
in France 7% [15]. This study indicates bed utilisation in
the UK is comparable to that seen in Portugal and Italy
but such a direct comparison may have limited validity
since different bed utilisation tools have been used.
The finding that many fewer patients remain in the
hospital with no morbidity (as defined by POMS) in the
US when compared with the UK suggests that bed util-
isation in the US is superior to that seen in the UK.
The implementation of ‘payment by results’ in the UK
aims to improve appropriate bed occupancy to optimise
patient care and improve efficiency. If the patients in
this study had been discharged when they first had no
morbidity defined by POMS, a saving of over £750,000
Ashby et al. Perioperative Medicine  (2015) 4:5 Page 7 of 7could have been made in 1 year (based on a cost of
£400 per bed-day). This money could be reinvested in
rehabilitation services with a strong emphasis on ther-
apies rather than being spent on unnecessary inpatient
medical care.
Conclusions
We believe that POMS is able to identify patients
remaining in hospital without clinically significant mor-
bidity and may be used prospectively as a bed utilisation
tool. To use the survey for this purpose, it may be useful
to add an additional measure to assess mobility.
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